Synthetic "Life," ethics, national security, and public discourse

Science

Volumn 329, Issue 5987, 2010, Pages 38-39

  Cho, Mildred K ^a   Relman, David A ^a,b  

^a STANFORD UNIVERSITY   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHICS; LIFE SCIENCE; NATIONAL SECURITY; PUBLIC ACCESS; RISK ASSESSMENT;

BIOLOGY; BIOMEDICINE; DISCOURSE ANALYSIS; ETHICS; GENETIC VARIABILITY; MEDICAL RESEARCH; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SHORT SURVEY; BACTERIAL GENOME; BIOENGINEERING; BIOETHICS; GENETIC ENGINEERING; GENETIC PROCEDURES; GENOMICS; METHODOLOGY; NOTE; ORGANIZATION AND MANAGEMENT; POLICY; PUBLIC OPINION; RISK ASSESSMENT; UNITED STATES;

BIOENGINEERING; BIOETHICAL ISSUES; GENETIC ENGINEERING; GENETIC TECHNIQUES; GENOME, BACTERIAL; GENOMICS; PUBLIC OPINION; PUBLIC POLICY; RISK ASSESSMENT; SECURITY MEASURES; UNITED STATES;

EID: 77954333550     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1193749     Document Type: Short Survey

References (25)

1. D. G. Gibson et al., Science 329, 52 (2010).
2. P. A. Carr, G. M. Church, Nat. Blotechnol. 27, 1151 (2009).
3. National Research Council, Globalization, Biosecurity, and the Future of the Life Sciences (National Academies Press, Washington, DC, 2006).
4. D. A. Relman, Nat. Immunol. 11, 275 (2010).
5. NSABB, Strategic Plan for Outreach and Education on Dual Use Research Issues (NSABB, NIH, Bethesda, MD, 2008); http://oba.od.nih.gov/biosecurity/PDF/ FinalNSABBReportonOutreachandEducationDec02008.pdf.
6. NSABB, Addressing Biosecurity Concerns Related to the Synthesis of Select Agents (NSABB, NIH, Bethesda, MD, 2006); http://oba.od.nih.gov/biosecurity/pdf/ Final-NSABB-Report-on-Synthetic-Genomics.pdf.
7. U.S. Department of Health and Human Services, Fed. Regist. 74, 62319 www.thefederalregister.com/d.p/2009-11-27-E9-28328(2009).
8. A. Casadevall, D. A. Relman, Nat. Rev. Microbiol. 8, 149 (2010).
9. M. K. Cho, D. Magnus, A. L. Caplan, D. McGee, Science 286, 2087, 2089 (1999).
10. CNN Wire Staff, www.cnn.com/2010/HEALTH/05/22/vati-can.synthetic.cell/ index.html
11. A. Rai, J. Boyle, PLoS Biol. 5, e58 (2007).
12. S. Maurer et al., From Understanding to Action: Community-Based Options for Improving Safety and Security in Synthetic Biology (University of California at Berkeley, Berkeley, CA, 2006).
13. J. Boldt, O. Müller, Nat. Biotechnol. 26, 387 (2008).
14. M. Garfinkel et al., Synthetic Genomics: Options for Governance (J. Craig Venter Institute, Rockville, MD; CSIS, Washington, DC; MIT, Cambridge, MA, 2007).
15. A. Balmer, P. Martin, Synthetic Biology: Social and Ethical Challenges (University of Nottingham Institute for Science and Society, Nottingham, UK, 2008).
16. M. Rodemeyer, in Synthetic Biology Project (Woodrow Wilson International Center for Scholars, Washington, DC, 2009), pp. 33-50.
17. E. Parens et al., in Synthetic Biology Project (Woodrow Wilson International Center for Scholars, Washington, DC, 2009), pp. 3-32.
18. S. Gaisser, T. Reiss, Syst. Synth. Biol. 3, 109 (2009).
19. M. Schmidt et al., Syst. Synth. Biol. 3, 3 (2009).
20. U.S. House Committee on Energy and Commerce, Hearing on Developments in Synthetic Genomics and Implications for Health and Energy, 27 May 2010; http://energycommerce.house.gov/index.php?option=com-content&view= article&id=2012:hearing-ondevelopments-in-synthetic-genomics-and- implications-forhealth-and-energy&catid=128:full-committee<emid=84.
21. B. H. Obama, Letter to Presidential Commission for the Study of Bioethical Issues, 20 May 2010; www.whitehouse.gov/blog/2010/05/20/synthesized- dna-and-presidential-commission-study-bioethical-issues
22. Z. Amsellem, B. A. Cohen, J. Gressel, Nat. Biotechnol. 20, 1035 (2002).
23. Editors, Nature 464, 649 (2010).
24. N. Wade, New York Times, 12 June 2010, p. A1.
25. M.K.C. is supported by NHGRI Grant P50 HG003389 and NIH grant U54 RR024374-01A1. D.A.R. is supported by NIH Pioneer Award DP1-OD000964 and the Thomas C. and Joan M. Merigan Endowment at Stanford University.